黑料网

Immunology: Current Research
黑料网

Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Commentary   
  • Immunol Curr Res 2022, Vol 6(3): 119
  • DOI: 10.4172/icr.1000119

Prognostic Biomarkers for COVID-19 Patients: Inhibitory Immune Checkpoint Receptors and Ligands

Hania Szajewska*
Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland
*Corresponding Author : Hania Szajewska, Department of Paediatrics, The Medical University of Warsaw, Warsaw, Poland, Email: hanias@gmail.com

Received Date: Apr 13, 2022 / Published Date: May 11, 2022

Citation: Szajewska H (2022) Prognostic Biomarkers for COVID-19 Patients: Inhibitory Immune Checkpoint Receptors and Ligands. Immunol Curr Res, 6: 119. Doi: 10.4172/icr.1000119

Copyright: © 2022 Szajewska H. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

International Conferences 2025-26
 
Meet Inspiring Speakers and Experts at our 3000+ Global

Conferences by Country

Medical & Clinical Conferences

Conferences By Subject

Top